ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Trapido To Lead NCI’s Epidemiology Program.

July 26, 2002

In Brief: Radiologists Elect Officers, Award Medals; FDA Advisors Okay Test For Breast Cancer

September 29, 1995

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

September 24, 1999

Paulette Gray named director of NCI Division of Extramural Activities.

April 22, 2005

L-PAM Benefit To Post-Menopausal Patients Challenged

October 29, 1976

In Brief: Elion, Schein, Johnson Head Societies; Phillips, Salmon Elected; McIntire, Pistenma to Leave NCI

June 3, 1983